Terms: = Leukemia AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
295 results:
1. Design, Synthesis, Computational Studies, and Anti-Proliferative Evaluation of Novel Ethacrynic Acid Derivatives Containing Nitrogen Heterocycle, Urea, and Thiourea Moieties as Anticancer Agents.
El Abbouchi A; Mkhayar K; Elkhattabi S; El Brahmi N; Hiebel MA; Bignon J; Guillaumet G; Suzenet F; El Kazzouli S
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611717
[TBL] [Abstract] [Full Text] [Related]
2. Single nucleotide polymorphisms conferring susceptibility to leukemia and oral mucositis: a multi-center pilot study of patients prior to conditioning therapy for hematopoietic cell transplant.
Mougeot JC; Beckman MF; Alexander AS; Hovan AJ; Hasséus B; Legert KG; Johansson JE; von Bültzingslöwen I; Brennan MT; Mougeot FB
Support Care Cancer; 2024 Mar; 32(4):220. PubMed ID: 38467943
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid leukemia.
Lima K; Carvalho MFL; Pereira-Martins DA; Nogueira FL; de Miranda LBL; Nascimento MCD; Cavaglieri RC; Schuringa JJ; Machado-Neto JA; Rego EM
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069220
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.
Huuhtanen J; Adnan-Awad S; Theodoropoulos J; Forstén S; Warfvinge R; Dufva O; Bouhlal J; Dhapola P; Duàn H; Laajala E; Kasanen T; Klievink J; Ilander M; Jaatinen T; Olsson-Strömberg U; Hjorth-Hansen H; Burchert A; Karlsson G; Kreutzman A; Lähdesmäki H; Mustjoki S
Leukemia; 2024 Jan; 38(1):109-125. PubMed ID: 37919606
[TBL] [Abstract] [Full Text] [Related]
5. A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia.
Vosgrau JS; Silva LAF; Filho VO; Matas CG
Clinics (Sao Paulo); 2023; 78():100234. PubMed ID: 37356412
[TBL] [Abstract] [Full Text] [Related]
6. FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells.
Levavasseur F; Oussous S; Zubaidan T; Kosmider O; Pendino F; Rombaut D; Bouscary D; Fontenay M; Lauret E; Dusanter-Fourt I
Blood Adv; 2023 Jul; 7(13):3265-3275. PubMed ID: 36930820
[TBL] [Abstract] [Full Text] [Related]
7. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
[TBL] [Abstract] [Full Text] [Related]
8. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.
Rzepiel A; Horváth A; Kutszegi N; Gézsi A; Sági JC; Almási L; Egyed B; Lőrincz P; Visnovitz T; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
Mol Cell Probes; 2023 Feb; 67():101893. PubMed ID: 36640912
[TBL] [Abstract] [Full Text] [Related]
9. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.
Lima K; Pereira-Martins DA; de Miranda LBL; Coelho-Silva JL; Leandro GDS; Weinhäuser I; Cavaglieri RC; Leal AM; da Silva WF; Lange APAL; Velloso EDRP; Griessinger E; Hilberink JR; Ammatuna E; Huls G; Schuringa JJ; Rego EM; Machado-Neto JA
Blood Cancer J; 2022 Nov; 12(11):151. PubMed ID: 36347832
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of a novel water-soluble, rapid-release triptolide prodrug with improved drug-like properties and high efficacy in human acute myeloid leukemia.
Kang D; Pan X; Song Y; Liu Y; Wang D; Zhu X; Wang J; Hu L
Eur J Med Chem; 2022 Dec; 243():114694. PubMed ID: 36115206
[TBL] [Abstract] [Full Text] [Related]
11. Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8
Cheng CC; Ho AS; Peng CL; Chang J; Sie ZL; Wang CL; Chen YL; Chen CY
Int Immunopharmacol; 2022 Nov; 112():109110. PubMed ID: 36037651
[TBL] [Abstract] [Full Text] [Related]
12. Fluorescence biosensing of the leukemia gene by combining Target-Programmed controllable signal inspiring engineering.
Li H; Pu J; Wang S; Yu R
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121579. PubMed ID: 35803107
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of Skp2 enhances doxorubicin-induced cell death in B cell precursor acute lymphoblastic leukemia.
Manafi Shabestari R; Chegeni R; Faranoush M; Zaker F; Safa M
Cell Biol Int; 2022 Jun; 46(6):895-906. PubMed ID: 35143089
[TBL] [Abstract] [Full Text] [Related]
14. Study of Glutathione S-transferase-P1 in cancer blood plasma after extraction by affinity magnetic nanoparticles and monitoring by MALDI-TOF, IM-Q-TOF and LC-ESI-Q-TOF MS.
Fasih Ramandi N; Soleimani Mashhadi I; Sharif A; Saeedi N; Ashabi MA; Faranoush M; Ghassempour A; Aboul-Enein HY
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1190():123091. PubMed ID: 34979454
[TBL] [Abstract] [Full Text] [Related]
15. In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets.
Carlet M; Völse K; Vergalli J; Becker M; Herold T; Arner A; Senft D; Jurinovic V; Liu WH; Gao Y; Dill V; Fehse B; Baldus CD; Bastian L; Lenk L; Schewe DM; Bagnoli JW; Vick B; Schmid JP; Wilhelm A; Marschalek R; Jost PJ; Miething C; Riecken K; Schmidt-Supprian M; Binder V; Jeremias I
Nat Commun; 2021 Sep; 12(1):5655. PubMed ID: 34580292
[TBL] [Abstract] [Full Text] [Related]
16. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
[TBL] [Abstract] [Full Text] [Related]
17. Role of glutathione S-transferase P1 polymorphism in early transplant complications in patients undergoing allogeneic stem cell transplantation.
Saritas H; Suyani E; Güntekin S; Zeynep AŞ; Ergün MA; Çelik B; Sucak GT
J Cancer Res Ther; 2021; 17(2):565-573. PubMed ID: 34121709
[TBL] [Abstract] [Full Text] [Related]
18. Discovery of a Candidate Containing an (
Zhang D; Li P; Gao Y; Song Y; Zhu Y; Su H; Yang B; Li L; Li G; Gong N; Lu Y; Shao H; Yu C; Huang H
J Med Chem; 2021 Jun; 64(11):7434-7452. PubMed ID: 34011155
[TBL] [Abstract] [Full Text] [Related]
19. Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia.
Sidhu J; Gogoi MP; Agarwal P; Mukherjee T; Saha D; Bose P; Roy P; Phadke Y; Sonawane B; Paul P; Saha V; Krishnan S
Pediatr Blood Cancer; 2021 Nov; 68(11):e29046. PubMed ID: 33939263
[TBL] [Abstract] [Full Text] [Related]
20. Purification, crystallization, and X-ray diffraction analysis of myocyte enhancer factor 2D and DNA complex.
Chen Z; Wang Q; Zhang H; Ma X; Wu W; Cheng N; Zhang J; Zhou A; Li Y; Meng G
Protein Expr Purif; 2021 Mar; 179():105788. PubMed ID: 33221504
[TBL] [Abstract] [Full Text] [Related]
[Next]
